DST: If you want the .pdf of the article at the URLOriginally Posted by DrSmellThis
below, I will need your current email address.
[url]http://www.haworthpress.com/store/ArticleAbstract.asp?sid=F1AJ71WMKCP48HTMPW51HDT2GP 7Q5DS7&ID=90566[/ur
l]
Isolation of the VNO wasOriginally Posted by DrSmellThis
initially linked to a patented process/delivery system as I recall. This was seen by many researchers to be a 2nd
red flag with regard to findings that could not be independently replicated on picogram amounts of "active"
compounds.
In the most recently reported published findings: "Thirty milligrams of AND..., were deposited in
pure form into a 60ml... opaque jar, to be smelled by participants."
From a human VNO activation to effect
approach, it's picogram amounts and unreplicated data. From the more current non-VNO approach we're seeing effects
with (let me check my math... uh?) -- a lot more of the compound.
It's hard for me to imagine any woman
ever being naturally exposed to 20 sniffs of 30 milligrams of AND. So, while it's good to see reports of hormonal,
mood, and arousal change, I'm not sure how all this translates to product development.
Seems we've now gone
from activating the VNO with picogram amounts of AND, blocking the VNO and showing that it makes a difference
(though the data may not be published or replicated) and finally come round to attacking the human
olfactory/pheromonal processing system (sans VNO mention?) with massive doses of chemical.
James V.
Kohl
author of a less recent review at: http://www.nel.edu/22_5/NEL220501R01_Review.htm
Bookmarks